3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
3
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Recurrence
2
Multiple Myeloma
2
Lymphoma
2
Burkitt Lymphoma
2
Pancreatic Neoplasms
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia
1
Carcinoma, Pancreatic Ductal
1
Interventions
Gemcitabine
21
130-nm albumin-bound paclitaxel
8
irinotecan sucrosofate
7
Oxaliplatin
7
Leucovorin
7
Fluorouracil
7
Taxes
5
Drug Therapy
5
Albumin-Bound Paclitaxel
4
toripalimab
3
Specimen Handling
3
S 1 (combination)
3
Paclitaxel
3
Irinotecan
3
Injections
3
zimberelimab
2
surufatinib
2
camrelizumab
2
Pemetrexed
2
Pancreaticoduodenectomy
2
Magnetic Resonance Spectroscopy
2
Exercise
2
Capecitabine
2
Blood Specimen Collection
2
Biopsy
2
trastuzumab deruxtecan
1
sintilimab
1
semaglutide
1
potassium oxonate
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Pancreatic Neoplasms
×
Immunotherapy, Adoptive
×
Clear all
NCT07153289
2025-09-03
ResCPa
University Hospital Tuebingen
Phase 1/2
Not yet recruiting
38 enrolled